AACR Stories
AACR Drug Discovery and Development (AACR D3): Redefining the Oncology Drug Discovery and Development Ecosystem
Learn More
AACR Drug Discovery and Development (AACR D3): Redefining the Oncology Drug Discovery and Development Ecosystem
Learn More
Cancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn MoreThe inaugural AACR Pediatric Cancer Progress Report highlights research-driven advances in the prevention, detection, and treatment of childhood cancers.
Read the ReportChildhood rhabdomyosarcoma is the most common type of soft tissue sarcoma in children. July is Sarcoma Awareness Month.
Learn MoreTwenty-four eminent scientists were elected Fellows of the AACR Academy, Class of 2026, for their pioneering discoveries that have accelerated progress in cancer science and medicine.
Learn MoreThe latest issue of Leading Discoveries is now available online, highlighting research-driven progress in cancer science and medicine.
Read Leading DiscoveriesWhether honoring a special person or a special day, a donation to the American Association for Cancer Research has a lasting impact.
Donate NowSession recordings are available for viewing to registered attendees through October 31. Registration remains open for the on-demand virtual meeting.
The AACR Cancer Disparities Progress Report 2026 provides a comprehensive overview of the latest research on cancer disparities and calls for policies to reduce disparities and achieve cancer health equity.
Learn MoreThe AACR and its more than 61,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreThe AACR Pediatric Cancer Progress Report 2025 highlights the remarkable progress against childhood cancers driven by discoveries across the basic, translational, clinical, and population sciences.
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2023
Learn Moretherapeutics were approved for new or expanded uses by the FDA from July 1, 2024, to June 30, 2025
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn MoreYour donation to the American Association for Cancer Research helps our more than 65,000 members worldwide drive progress against cancer.
Donate Now
